[Comparative clinical investigations with the new antimycotic agent isoconazole nitrate and its combination with diflucortolone-21-valerate in the case of inflammatory and eczematised dermatomycoses].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D005448:Fluocortolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008825:Miconazole / Q000031:analogs & derivatives; D008875:Middle Aged; D009824:Ointments; D011244:Pregnadienediols / Q000031:analogs & derivatives*
D000935:Antifungal Agents; D002722:Chlorobenzenes; D004338:Drug Combinations; D007093:Imidazoles; D009824:Ointments; D011244:Pregnadienediols; D005448:Fluocortolone; D008825:Miconazole; C020382:isoconazole
Vergleichende klinische untersuchungen mit dem neuen Antimykotikum Isoconazolnitrat und seiner Kombination mit Diflucortolon-21-valerat bei entzündlichen und ekzematisierten Dermatomykosen.